에 대한 최신 뉴스 Marsh & McLennan (NYSE:MMC) 주식

Marsh & McLennan

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

마시 &amp; 매클레넌(NYSE:MMC)은 목요일에 예상보다 더 나은 3분기 실적을 발표했다. 이 회사는 시카고에 본사를 둔 위험관리 및 보험 중개 기업이다.

이 분석가들은 긍정적인 실적을 반영하여 마시 &amp; 매클레넌에 대한 주가 목표를 상향

Pre-Market Outlook

NFLX

STLD

목요일 아침 (현지 시간 기준) 미국 주식 선물이 하락세로 거래되면서 오늘 투자자의 관심을 끌 수 있는 주식은 다음과 같다: 1. 월스트리트는 트래블러스 컴퍼니(NYSE:TRV)가 개장 전 분기 이익을 주당 3.64달러, 매출은 114억 9천만 달러로 발표할 것을 예상하고 있다. 트래블러스의 주식은 애프터 마켓에서 0.9% 상승하여 242.95달러에 거래되었다.

목요일 주목해야 할 주식: 알코아, 넷플릭스, 트래블러스 그리고 2종목

Equities

Movers

General

버크셔 해서웨이(NYSE:BRK)의 보험 운영 부회장인 아지트 자인(Ajit Jain)은 사이버 보험이 요즘 매우 세련된 공간이 되었다고 말했다. 지난 몇 년 동안 사이버 보험은 전 세계적으로 최소 100억 달러 규모의 시장이 되었다.지난 토요일 네브래스카주 오마하에서 열린 버크셔 해서웨이의 연례 주주총회에서 자인은 사이버 보험의 수익성도 전체 보험료(프리미엄)의 약 20%로 상당히 높다고 말했다.

버크셔 해서웨이의 아지트 자인은 위험 속에서 사이버 보험에 대해 주의 경고

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Companies Inc

NYLI MacKay California Muni Intermediate ETF

Members Co Ltd

MAG MILE CAPITAL,INC by Mag Mile Capital Inc.

Mag Mile Capital Inc

Andean Silver Ltd

Mind Medicine Inc Warrants(11/12/2023)

Across the recent three months, 10 analysts have shared their insights on Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $235.8, a high estimate of $259.00, and a low estimate of $212.00. Surpassing the previous average price target of $228.11, the current average has increased by 3.37%.
<img src="https://www.benzinga.com/files/images/story/2025/1736535624_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Marsh &amp; McLennan. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Underperform</td>
<td>$214.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$235.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$242.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$242.00</td>
<td>-</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$246.00</td>
<td>$236.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$228.00</td>
<td>$217.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$259.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Underperform</td>
<td>$212.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Harry Fong</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Neutral</td>
<td>$230.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$242.00</td>
<td>$232.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Marsh &amp; McLennan. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Marsh &amp; McLennan compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Marsh &amp; McLennan's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Marsh &amp; McLennan's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Marsh &amp; McLennan analyst ratings.</a>
<h2>Get to Know Marsh &amp; McLennan Better</h2>
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
<h3>Marsh &amp; McLennan: A Financial Overview</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Marsh &amp; McLennan's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 5.85%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Marsh &amp; McLennan's net margin excels beyond industry benchmarks, reaching 13.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Marsh &amp; McLennan's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Marsh &amp; McLennan's ROA stands out, surpassing industry averages. With an impressive ROA of 1.52%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.08.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 10 Analysts Discuss Marsh & McLennan Stock

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and raises the price target from $212 to $214.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan, Raises Price Target to $214

JP Morgan analyst Jimmy Bhullar maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $230 to $235.

JP Morgan Maintains Neutral on Marsh & McLennan, Raises Price Target to $235

Marsh & McLennan's Marsh McLennan Agency Acquires Acumen Solutions Group, Terms Not Disclosed

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 2.89% on an annualized basis producing an average annual return of 14.32%. Currently, Marsh &amp; McLennan has a market capitalization of $104.11 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 10 years ago, it would be worth $3,762.06 today based on a price of $211.98 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735658107_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 10 years by 2.76% on an annualized basis producing an average annual return of 13.69%. Currently, Marsh &amp; McLennan has a market capitalization of $103.31 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 10 years ago, it would be worth $360.25 today based on a price of $210.35 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734647416_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today

RBC Capital analyst Scott Heleniak upgrades Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) from Sector Perform to Outperform and raises the price target from $242 to $250.

Upgrades

RBC Capital Upgrades Marsh & McLennan to Outperform, Raises Price Target to $250

Marsh &amp; McLennan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has fallen 11.34% since its last report. The company recently reported that it has 3.49 million shares sold short, which is 0.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733942712_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Marsh &amp; McLennan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Marsh &amp; McLennan's peer group average for short interest as a percentage of float is 2.81%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(MMC) - Analyzing Marsh & McLennan's Short Interest

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 2.45% on an annualized basis producing an average annual return of 16.09%. Currently, Marsh &amp; McLennan has a market capitalization of $112.78 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 5 years ago, it would be worth $2,108.08 today based on a price of $229.63 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732543245_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today

Evercore ISI Group analyst David Motemaden reinstates Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Outperform and announces $242 price target.

Initiation

Evercore ISI Group Reinstates Outperform on Marsh & McLennan, Announces $242 Price Target

Barclays analyst Alex Scott maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and raises the price target from $236 to $246.

Barclays Maintains Equal-Weight on Marsh & McLennan, Raises Price Target to $246

Marsh &amp; McLennan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) short percent of float has fallen 5.36% since its last report. The company recently reported that it has 4.30 million shares sold short, which is 1.06% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.27 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Marsh &amp; McLennan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731514522_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Marsh &amp; McLennan has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Marsh &amp; McLennan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Marsh &amp; McLennan's peer group average for short interest as a percentage of float is 3.40%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Marsh & McLennan?

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 2.62% on an annualized basis producing an average annual return of 16.31%. Currently, Marsh &amp; McLennan has a market capitalization of $108.69 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 5 years ago, it would be worth $2,141.67 today based on a price of $221.31 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730145614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMO Capital analyst Michael Zaremski maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Market Perform and raises the price target from $217 to $228.

BMO Capital Maintains Market Perform on Marsh & McLennan, Raises Price Target to $228

UBS analyst Brian Meredith maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Buy and raises the price target from $255 to $259.

UBS Maintains Buy on Marsh & McLennan, Raises Price Target to $259

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and raises the price target from $209 to $212.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan, Raises Price Target to $212

Wells Fargo analyst Elyse Greenspan maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and lowers the price target from $212 to $211.

Wells Fargo Maintains Equal-Weight on Marsh & McLennan, Lowers Price Target to $211

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) reported better-than-expected third-quarter <a href="https://www.benzinga.com/quote/MMC/earnings">earnings on Thursday</a>.
Marsh &amp; McLennan reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.57 per share. The company reported quarterly sales of $5.70 billion which met the analyst consensus estimate.
John Doyle, President and CEO, said: &#8220;This was a milestone quarter for Marsh McLennan as we delivered strong results and announced the acquisition of McGriff Insurance Services. Our performance demonstrated continued momentum, with 5% underlying revenue growth, 110 basis points of margin expansion and adjusted EPS growth of 4%, or 11% excluding a one-time tax benefit a year ago. We remain on track for another great year in 2024.&#8221;
M&amp;T Bank shares fell 0.4% to trade at $198.04 on Friday.
These analysts made changes to their price targets on M&amp;T Bank following earnings announcement.
<ul>
<li>RBC Capital analyst Scott Heleniak maintained Marsh &amp; McLennan with a Sector Perform and raised the price target from $232 to $242.</li>
<li>Roth MKM analyst Harry Fong maintained Marsh &amp; McLennan with a Neutral and raised the price target from $220 to $230.</li>
</ul>
Considering buying MMC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-1024x490.png" alt="" class="wp-image-603119" style="width:669px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-1024x490.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-300x144.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-768x368.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170.png 1357w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

These Analysts Boost Their Forecasts On Marsh & McLennan Following Upbeat Earnings

Roth MKM analyst Harry Fong maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $220 to $230.

Roth MKM Maintains Neutral on Marsh & McLennan, Raises Price Target to $230

RBC Capital analyst Scott Heleniak maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Sector Perform and raises the price target from $232 to $242.

RBC Capital Maintains Sector Perform on Marsh & McLennan, Raises Price Target to $242

Marsh McLennan Agency acquires Acumen Solutions Group

The company states: "Marsh McLennan (MMC) Agency, a business of Marsh and a leading provider of business insurance, employee health and benefits, r...

Marsh McLennan acquires Acumen Solutions, terms not stated

JPMorgan analyst Jimmy Bhullar raised the firm's price target on Marsh McLennan (MMC) to $235 from $230 and keeps a Neutral rating on the shares. T...

Marsh McLennan price target raised to $235 from $230 at JPMorgan

Barclays analyst Alex Scott maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of $246.00....

Barclays Keeps Their Hold Rating on Marsh & Mclennan Companies (MMC)

Keefe Bruyette analyst Meyer Shields raised the firm's price target on Marsh McLennan (MMC) to $214 from $212 and keeps an Underperform rating on t...

Marsh McLennan price target raised to $214 from $212 at Keefe Bruyette

Insurers gain Wall Street's vote of confidence, with caveats

Most and least shorted S&P 500 financial stocks in December

As of Jan. 7, 2025, UnitedHealth Group is the country's most valuable insurance company, with a market cap of $473 billion.

Visualizing America's $1.7 Trillion Insurance Industry

Marsh & McLennan declares $0.815 dividend

Insurance stocks on watch as Hughes Fire quickly spreads to over 3.4K acres north of LA

CINF

EHTH

ERIE

KINS

KMPR

ROOT

SCHW

SPGI

TROW

Press Releases

Marsh McLennan Announces Pricing of $7.25 Billion Senior Notes Offering

Marsh McLennan's Mercer Completes Acquisition of Cardano

Marsh McLennan Completes Acquisition of McGriff Insurance Services

RMA's Annual CRO Survey Reveals Cybersecurity, Fraud, and Rapid Response as Key Banking Risks in 2025

Employers Enhanced Health Benefits in 2024, Adding Coverage for Weight-Loss Medications and IVF Despite Growing Health Costs, Mercer Survey Finds

Credit Benchmark and Oliver Wyman Launch IRB Nexus to Help Banks Improve Model Performance and Calibration

Despite Economic Uncertainty, US Employers Maintain Elevated Compensation Budgets for 2025, According to Mercer

Marsh McLennan Agency Acquires Acumen Solutions Group

Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30

Marsh McLennan Declares Quarterly Cash Dividend

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Waterdrop

Willis Towers Watson Public Limited Company - Ordinary Shares

Willis Towers Watson

XChange TEC.INC - American Depositary Shares

XChange Tec

Zhibao Technology Inc. - Class A Ordinary Shares

Zhibao Technology

Keefe, Bruyette & Woods

JP Morgan

RBC Capital

Evercore ISI Group

Barclays

Marsh McLennan

마시 &amp; 매클레넌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>)은 목요일에 예상보다 더 나은 3분기 <a href="https://www.benzinga.com/quote/MMC/earnings">실적</a>을 발표했다. 이 회사는 시카고에 본사를 둔 위험관리 및 보험 중개 기업이다.
마시 &amp; 매클레넌은 주당 1.63달러의 분기 이익을 발표하여 애널리스트의 컨센서스 예상치인 1.57달러를 초과했다. 분기 매출은 57억 달러로, 애널리스트의 컨센서스 예상치에 부합했다.
존 도일(John Doyle) 사장 겸 CEO는 &#8220;이번 분기는 마시 매클레넌에게 중요한 이정표가 되었으며, 강력한 실적을 보여주고 맥그리프 보험 서비스(McGriff Insurance Services) 인수를 발표한 분기이다. 우리의 성과는 지속적인 모멘텀을 보여주었으며, 기초 매출은 5% 성장하고, 마진이 110bp(베이시스 포인트) 확장되었으며, 조정된 EPS는 4% 증가했다. 일회성 세금 혜택을 제외하면 11% 증가했다. 우리는 2024년에도 또 다른 훌륭한 해를 맞이할 준비가 되어 있다&#8221;고 말했다.
마시 &amp; 매클레넌의 주식은 금요일 1% 하락하여 224.66달러에 마감되었다.
몇몇 애널리스트들은 실적 발표 후 마시 &amp; 매클레넌의 목표 주가를 변경했다.
<ul>
<li>RBC 캐피털의 애널리스트 스캇 헬레니악(Scott Heleniak_은 마시 &amp; 매클레넌에 대해 섹터 수행을 유지하고 목표 주가를 232달러에서 242달러로 상향 조정했다.</li>
<li>로스 MKM의 애널리스트 해리 퐁(Harry Fong)은 마시 &amp; 매클레넌에 대해 중립을 유지하고 목표 주가를 220달러에서 230달러로 상향 조정했다.</li>
</ul>
MMC 주식 구매를 고려 중이신가요? 애널리스트들의 생각은 다음과 같다: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" class="wp-image-603119" style="width: 669px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-1024x490.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-1024x490.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-300x144.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170-768x368.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18122114/image-170.png 1357w" alt="" width="1024" height="490" /></figure>
추가 읽기:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">애브비는 ‘매우 잘 하고 있지만&#8217; 짐 크레이머가 가장 좋아하는 것은 애벗 래버러토리스이다.</a></li>
</ul>
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이 분석가들은 긍정적인 실적을 반영하여 마시 & 매클레넌에 대한 주가 목표를 상향

목요일 아침 (현지 시간 기준) 미국 주식 선물이 하락세로 거래되면서 오늘 투자자의 관심을 끌 수 있는 주식은 다음과 같다:
1. 월스트리트는 트래블러스 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>)가 개장 전 분기 이익을 주당 3.64달러, 매출은 114억 9천만 달러로 발표할 것을 예상하고 있다. 트래블러스의 주식은 애프터 마켓에서 0.9% 상승하여 242.95달러에 거래되었다.
2. 알루미늄 생산업체 알코아(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>)는 예상보다 좋은 3분기 실적을 발표했니다. 이 회사는 조정된 주당 57센트의 이익을 발표하였고, 이는 시장 예상치인 28센트를 크게 상회한 결과이다. 알코아 주식은 애프터 마켓에서 6% 상승하여 44.61달러에 거래되었다.
3. 분석가들은 넷플릭스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)가 분기 이익을 주당 5.12달러, 매출은 97억 7천만 달러로 발표할 것으로 예상하고 있다. 이 회사는 시장이 마감된 후에 실적을 발표할 것이다. 넷플릭스의 주식은 애프터 마켓에서 0.1% 하락하여 701.61달러에 거래되었다.
자세한 내용은 <a href="https://www.benzinga.com/premarket/">여기에서 프리마켓 보도를 확인하세요</a>
4. 스틸 다이내믹스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>)는 수요일 예상보다 강력한 3분기 실적을 발표했다. 이 회사는 3분기에 320만 톤의 철강을 출하하였고, 운영 현금 흐름이 7억 6천만 달러였다고 발표했다. 스틸 다이내믹스의 주식은 애프터 마켓에서 1.9% 상승하여 132.26달러에 거래되었다.
5. 분석가들은 마시 &amp; 매클레넌 컴퍼니스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>)가 개장 전 분기 이익을 주당 1.61달러, 매출은 57억 달러로 발표할 것을 예상하고 있다. 마시 &amp; 매클레넌의 주식은 애프터 마켓에서 0.5% 상승하여 228.99달러에 거래되었다.
이것도 확인해보세요:
<ul>
<li> <a href="https://www.benzinga.com/news/24/10/41366043/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">월스트리트 최고의 분석가들이 고배당 수익률을 제공하는 3개 소비재 주식에 대한 의견을 제시</a></li>
</ul>
사진 출처: Wikimedia
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

버크셔 해서웨이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)의 보험 운영 부회장인 아지트 자인(Ajit Jain)은 사이버 보험이 요즘 매우 세련된 공간이 되었다고 말했다. 지난 몇 년 동안 사이버 보험은 전 세계적으로 최소 <a href="https://www.benzinga.com/general/24/02/36987783/scott-mayor-founder-of-endurance-advises-businesses-on-managing-cyber-risk" target="_blank" rel="noreferrer noopener">100억 달러 규모의 시장</a>이 되었다.
지난 토요일 네브래스카주 오마하에서 열린 버크셔 해서웨이의 연례 주주<a href="https://www.youtube.com/watch?v=X3wLdzddRtI" target="_blank" rel="noreferrer noopener">총회</a>에서 자인은 사이버 보험의 수익성도 전체 보험료(프리미엄)의 <a href="https://www.benzinga.com/news/24/05/38630719/warren-buffett-fears-the-ai-genie-thats-part-out-of-the-bottle-but-agrees-it-has-potential-to-do-goo" target="_blank" rel="noreferrer noopener">약 20%</a>로 상당히 높다고 말했다.
그러나 그는 버크셔가 다음과 같은 이유로 사이버 보험 책임을 고려할 때 매우 신중한 경향이 있다고 말했다:
<ul>
<li>일회성 손실과 사이버 손실에 대한 집계 잠재력을 파악하는 것은 어렵다.</li>
<li>자인에 따르면 일부 클라우드 운영이 중단되면 집계 손실이 엄청날 수 있으며 &#8220;최악의 경우 한도&#8221;를 이해할 수 없다는 점이 우리를 두렵게 한다.</li>
<li>사이버 보험의 손실 비용은 단일 손실뿐만 아니라 시간에 따른 손실까지 이해하기 어렵다.</li>
</ul>
&#8220;우리는 이 분야를 꽤 잘 관리했으며 지난 4-5년 동안 프리미엄 손실의 1달러 중 100센트 중 40센트 이상은 넘지 않았을 것으로 생각한다&#8221;고 자인이 덧붙였다.
그러나 자인은 현재 실제 손실 비용을 완전히 이해할 수 있는 충분한 데이터가 없다고 강조했다.
자인은 "[직원들]이 사이버 보험에 가입하지 못하도록 했다"고 말했다. "사이버 보험 증권을 작성할 때마다 돈을 잃는다."
결과적으로 사이버 보험은 대규모 사업이 될 것으로 예상되지만, 막대한 손실을 초래할 수도 있다.
&#8220;우리의 방법은 현재 우리가 어떤 의미 있는 데이터에 액세스할 때까지 이 분야에서 거리를 둔 상태로 있다&#8221;고 자인이 말했다.
국제통화기금(IMF)의 <a href="https://www.imf.org/en/Blogs/Articles/2024/04/09/rising-cyber-threats-pose-serious-concerns-for-financial-stability">보고서</a>에 따르면 코로나19 이후 사이버 공격은 두 배 이상 급증했다. 많은 회사가 경미한 직접적인 손실을 입었지만 에퀴팩스(Equifax)와 같은 일부 회사는 상당한 피해를 입었다. 예를 들어 에퀴팩스는 1억 5천만 명의 소비자에게 영향을 미친 2017년 주요 데이터 침해 사건 이후 침해 보상과 데이터 보안 전환에 10억 달러 이상을 지출했다.
사이버 보험을 제공하는 주요 미국 상장 기업을 살펴보면 다음과 같다:
<ul>
<li>마쉬 앤 맥레넌(Marsh &amp; McLennan Companies, Inc.) 보통주(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>)</li>
<li>에이온(Aon Plc) 클래스 A 보통주(아일랜드)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>)</li>
<li>아서 J 갤러거(Arthur J. Gallagher &amp; Co.) 보통주(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>)</li>
<li>브라운 앤 브라운(Brown &amp; Brown, Inc.) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>)</li>
<li>윌리스 타워 왓슨(Willis Towers Watson Public Limited Company) &#8211; 보통주(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>)</li>
</ul>
버크셔 해서웨이는 토요일 인수 및 투자 수입 모두에서 보험 사업의 강세에 힘입어 <a href="https://www.businesswire.com/news/home/20240504932623/en/Berkshire-Hathaway-Inc.-First-Quarter-2024-Earnings-Release" target="_blank" rel="noreferrer noopener">1분기</a> 영업 이익이 견실한 증가세를 기록했다.
버크셔 해서웨이(Berkshire Hathaway)는 토요일, 보험 비즈니스의 강도로 인해 언더라이팅과 투자 수입 모두에서 강세로 <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">억제된</a> <a href="https://www.businesswire.com/news/home/20240504932623/en/Berkshire-Hathaway-Inc.-First-Quarter-2024-Earnings-Release" target="_blank" rel="noreferrer noopener">분기</a> 영업이익을 기록했습니다. <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">지난해 같은 분기의 80.65억 달러 대비</a> 약 39% 이상 증가한 약 112.2억 달러의 분기 영업 이익을 기록했다.
사진: 셔터스톡(Shutterstock)

CNN 머니(Money)의 ‘공포와 탐욕&#8217; 지수는 전반적인 시장 심리가 더욱 악화하고 있는 가운데 수요일에도 여전히 ‘공포&#8217; 구간에 머물렀다.
미국의 주식은 수요일 미국 S&amp;P 500 지수가 네 번째 하락하여 낙폭이 커졌다.
경제지표에 따르면, 4월 12일로 끝난 주 미국의 원유 재고는 전주의 584만 1,000배럴 증가에 비해 273만 5,000만 배럴 증가했다.
U.S. 뱅코프(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>)는 수요일에 긍정적인 2024 연도 1분기 실적을 보고했다. 유나이티드 항공(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>)의 주가는 회사가 예상보다 나은 분기 실적을 보고한 후 수요일에 17% 이상 급등했다.
S&amp;P 500의 대부분의 업종은 정보기술(IT), 부동산, 임의 소비재 주식이 수요일에 가장 큰 손실을 기록하면서 부정적인 메모로 마감했다. 그러나 유틸리티 및 필수 소비재 주식은 전반적인 시장 추세를 거스르며 세션을 높게 마감했다.
수요일 현재 지수는 34.4로 이전 수치인 37.6과 비교하여 &#8220;공포&#8221; 영역에 머물렀다.
CNN 비즈니스의 공포와 탐욕 지수(Fear &amp; Greed Index)란?
공포와 탐욕 지수(Fear &amp; Greed Index)는 현재 시장 심리를 측정하는 지표입니다. 이는 두려움이 높을수록 주가에 압력을 가하는 반면, 탐욕이 높을수록 반대 효과가 나타난다는 전제에 기초한다. 지수는 7개의 동일 가중치 지표를 기반으로 계산된다. 지수 범위는 0에서 100까지이며, 0은 최대 공포를 나타내고 100은 최대 탐욕을 나타낸다.
다음 읽기: <a href="https://www.benzinga.com/news/earnings/24/04/38285336/how-to-earn-500-a-month-from-intel-stock-ahead-of-q1-earnings">인텔(인텔 주식) 분기 회계 성과 발표 이전, 인텔 주식에서 매달 500달러의 수익을 얻는 방법</a>

투자자 심리 부진, S&P 500은 4일 연속 하락

미국 주식 선물이 목요일 오전 상승한 가운데, 투자자들의 관심을 끌 수 있는 몇 가지 주식은 다음과 같다:
<a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>의 데이터에 의하면, 월가는 D.R. 호튼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>)의 시장 개장 전 주당 3.06달러의 분기 실적과 82.7억 달러의 매출을 예상하고 있다. D.R. 호튼은 시간 외 거래에서 0.5% 하락한 145.00달러에 거래되었다.
시노버스 파이낸셜 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>)는 수요일 1분기에 대해 예상보다 더 나쁜 결과를 발표했다. 시노버스 파이낸셜 주식은 시간 외 거래에서 2.5% 하락한 35.70달러에 거래되었다.
분석가들은 넷플릭스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)의 분기 실적이 주당 4.52달러, 92.8억 달러의 매출을 발표할 것으로 전망했다. 이에 대한 회사의 실적은 시장 마감 후에 발표될 예정이다. 넷플릭스의 주식은 시간 외 거래에서 0.2% 상승한 614.99달러에 거래되다.
알코아(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>)는 첫 분기에 대해 예상보다 더 나은 판매 실적을 발표했다. 이 회사는 여전히 연간 알루미나 생산량이 980만~1,000만 톤에 달하고, 연간 알루미나 출하량은 1,270만~1,290만 톤에 이를 것으로 예상하고 있다. 알코아 주가는 시간 외 거래에서 3% 상승한 36.63달러를 기록했다.
분석가들은 투자자들이 시장이 열리기 전에 마쉬 앤 맥레넌(Marsh &amp; McLennan Companies, Inc) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>)의 주당 2.80달러의 분기 실적과 63.9억 달러의 매출을 예상하고 있다. 시간 외에서 마쉬 앤 맥레넌 주식은 0.2% 상승한 198.00달러에 거래되었다.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38285336/how-to-earn-500-a-month-from-intel-stock-ahead-of-q1-earnings">Q1 실적 발표 전 인텔 주식에서 매달 500달러 버는 방법</a>

Comments

Marsh & McLennan

뉴스

에 대한 최신 뉴스 Marsh & McLennan (NYSE:MMC) 주식

토요일, 10월 19, 2024

목요일, 10월 17, 2024

월요일, 5월 06, 2024

목요일, 4월 18, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌